Total Payments
$218,852
2024 Payments
$2,304
Companies
21
Transactions
230
Medicare Patients
5,620
Medicare Billing
$481,016
Payment Breakdown by Category
Other$196,383 (89.7%)
Travel$14,108 (6.4%)
Food & Beverage$7,902 (3.6%)
Consulting$450.00 (0.2%)
Education$9.60 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $196,383 | 79 | 89.7% |
| Travel and Lodging | $14,108 | 34 | 6.4% |
| Food and Beverage | $7,902 | 115 | 3.6% |
| Consulting Fee | $450.00 | 1 | 0.2% |
| Education | $9.60 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $154,174 | 115 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $32,211 | 45 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $24,094 | 23 | $0 (2018) |
| Medtronic Vascular, Inc. | $3,335 | 13 | $0 (2018) |
| Philips Electronics North America Corporation | $1,649 | 4 | $0 (2023) |
| Nuwellis, Inc. | $1,382 | 3 | $0 (2022) |
| CHF Solutions, Inc | $618.07 | 6 | $0 (2020) |
| Abbott Laboratories | $400.49 | 4 | $0 (2023) |
| CVRx, Inc. | $246.84 | 2 | $0 (2023) |
| ABIOMED | $150.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,304 | 9 | AstraZeneca Pharmaceuticals LP ($1,983) |
| 2023 | $3,972 | 11 | AstraZeneca Pharmaceuticals LP ($2,546) |
| 2022 | $8,112 | 14 | AstraZeneca Pharmaceuticals LP ($6,141) |
| 2021 | $16,675 | 21 | AstraZeneca Pharmaceuticals LP ($16,479) |
| 2020 | $5,073 | 10 | AstraZeneca Pharmaceuticals LP ($5,051) |
| 2019 | $14,186 | 12 | Novartis Pharmaceuticals Corporation ($13,704) |
| 2018 | $63,040 | 64 | Novartis Pharmaceuticals Corporation ($51,878) |
| 2017 | $105,489 | 89 | Novartis Pharmaceuticals Corporation ($88,592) |
All Payment Transactions
230 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/08/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $76.95 | General |
| Category: NEUROLOGY | ||||||
| 07/08/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/15/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/13/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Renal Denervation System | ||||||
| 03/12/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $44.48 | General |
| Category: Renal Denervation System | ||||||
| 02/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $123.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/16/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $153.36 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/08/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $149.26 | General |
| Category: Heart Failure | ||||||
| 10/18/2023 | Philips Electronics North America Corporation | (9547) IGT Systems Undivided (Device) | Travel and Lodging | Cash or cash equivalent | $893.40 | General |
| Category: Medical Device | ||||||
| 09/19/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $100.28 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/07/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/01/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/01/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/15/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Rare Disease | ||||||
| 03/16/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 03/08/2023 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $129.60 | General |
| Category: Immunology | ||||||
| 02/23/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), BRILINTA | Food and Beverage | In-kind items and services | $33.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/07/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/02/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/02/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/29/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.06 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/28/2022 | Philips Electronics North America Corporation | (9547) IGT Systems Und (Device) | Travel and Lodging | Cash or cash equivalent | $232.38 | General |
| Category: Medical Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,197 | 1,695 | $340,060 | $107,866 |
| 2022 | 17 | 1,260 | 1,731 | $361,629 | $110,978 |
| 2021 | 19 | 1,606 | 2,269 | $455,824 | $143,082 |
| 2020 | 24 | 1,557 | 2,096 | $365,513 | $119,091 |
Total Patients
5,620
Total Services
7,791
Medicare Billing
$481,016
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 421 | 614 | $162,710 | $53,344 | 32.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 43 | 109 | $28,122 | $10,131 | 36.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 57 | 139 | $24,881 | $8,540 | 34.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 47 | $26,038 | $7,941 | 30.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 57 | $28,557 | $7,567 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $20,100 | $6,353 | 31.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 325 | 346 | $14,186 | $3,520 | 24.8% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2023 | 27 | 111 | $13,542 | $3,503 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 55 | $10,065 | $3,317 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 21 | $4,116 | $1,608 | 39.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 53 | 54 | $2,970 | $824.00 | 27.7% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 15 | 15 | $840.00 | $264.70 | 31.5% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 19 | 19 | $1,254 | $258.66 | 20.6% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2023 | 19 | 19 | $1,140 | $246.24 | 21.6% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 12 | 12 | $804.00 | $238.80 | 29.7% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 14 | 14 | $462.00 | $125.58 | 27.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 12 | 13 | $273.00 | $83.20 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 417 | 666 | $176,490 | $56,906 | 32.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 19 | 61 | $33,794 | $10,466 | 31.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 56 | 119 | $30,702 | $9,567 | 31.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 54 | 56 | $28,056 | $8,588 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 134 | 148 | $27,084 | $7,567 | 27.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 70 | $12,530 | $3,930 | 31.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 321 | 339 | $13,899 | $3,137 | 22.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $11,658 | $3,058 | 26.2% |
About Dr. Thomas O'brien, M.D
Dr. Thomas O'brien, M.D is a Cardiovascular Disease healthcare provider based in Liberty Township, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003844366.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas O'brien, M.D has received a total of $218,852 in payments from pharmaceutical and medical device companies, with $2,304 received in 2024. These payments were reported across 230 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($196,383).
As a Medicare-enrolled provider, O'brien has provided services to 5,620 Medicare beneficiaries, totaling 7,791 services with total Medicare billing of $481,016. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Advanced Heart Failure and Transplant Cardiology
- Location Liberty Township, OH
- Active Since 06/28/2006
- Last Updated 06/21/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1003844366
Products in Payments
- ENTRESTO (Drug) $150,948
- FARXIGA (Drug) $31,968
- SAMSCA (Drug) $24,094
- HeartWare HVAD (Device) $3,335
- Aquadex Smartflow Console (Device) $1,200
- (9547) IGT Systems Undivided (Device) $893.40
- (9547) IGT Systems Und (Device) $755.28
- Aquadex (Device) $618.07
- Barostim Neo System (Device) $246.84
- AQUADEX SMARTFLOW CONSOLE (Device) $182.45
- HeartMate 3 Left Ventricular Dev (Device) $153.61
- Impella (Device) $150.00
- CARDIOMEMS (Device) $149.26
- LifeVest (Device) $130.36
- TREMFYA (Drug) $129.60
- BRILINTA (Drug) $105.73
- Circulatory Support (Device) $97.62
- VYEPTI (Biological) $76.95
- SYMPLICITY G3 (Device) $59.01
- Veltassa (Drug) $22.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.